Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |